dc.contributor.author | Kerkmeijer, LGW | |
dc.contributor.author | Fuller, CD | |
dc.contributor.author | Verkooijen, HM | |
dc.contributor.author | Verheij, M | |
dc.contributor.author | Choudhury, A | |
dc.contributor.author | Harrington, KJ | |
dc.contributor.author | Schultz, C | |
dc.contributor.author | Sahgal, A | |
dc.contributor.author | Frank, SJ | |
dc.contributor.author | Goldwein, J | |
dc.contributor.author | Brown, KJ | |
dc.contributor.author | Minsky, BD | |
dc.contributor.author | van Vulpen, M | |
dc.contributor.author | MR-Linac Consortium Clinical Steering Committee, | |
dc.date.accessioned | 2017-09-06T10:53:58Z | |
dc.date.accessioned | 2017-09-07T15:24:56Z | |
dc.date.issued | 2016-10-13 | |
dc.identifier.citation | Frontiers in oncology, 2016, 6 pp. 215 - ? | |
dc.identifier.issn | 2234-943X | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/815 | |
dc.identifier.eissn | 2234-943X | |
dc.identifier.doi | 10.3389/fonc.2016.00215 | |
dc.description.abstract | An international research consortium has been formed to facilitate evidence-based introduction of MR-guided radiotherapy (MR-linac) and to address how the MR-linac could be used to achieve an optimized radiation treatment approach to improve patients' survival, local, and regional tumor control and quality of life. The present paper describes the organizational structure of the clinical part of the MR-linac consortium. Furthermore, it elucidates why collaboration on this large project is necessary, and how a central data registry program will be implemented. | |
dc.format | Electronic-eCollection | |
dc.format.extent | 215 - ? | |
dc.language | eng | |
dc.language.iso | eng | |
dc.publisher | FRONTIERS MEDIA SA | |
dc.relation.replaces | https://repository.icr.ac.uk/handle/internal/812 | |
dc.relation.replaces | internal/812 | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0 | |
dc.subject | MR-Linac Consortium Clinical Steering Committee | |
dc.title | The MRI-Linear Accelerator Consortium: Evidence-Based Clinical Introduction of an Innovation in Radiation Oncology Connecting Researchers, Methodology, Data Collection, Quality Assurance, and Technical Development. | |
dc.type | Journal Article | |
dcterms.dateAccepted | 2016-09-28 | |
rioxxterms.versionofrecord | 10.3389/fonc.2016.00215 | |
rioxxterms.licenseref.uri | https://creativecommons.org/licenses/by/4.0 | |
rioxxterms.licenseref.startdate | 2016-01 | |
rioxxterms.type | Journal Article/Review | |
dc.relation.isPartOf | Frontiers in oncology | |
pubs.notes | Not known | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Biology | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Biology/Targeted Therapy | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Targeted Therapy | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Biology | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Biology/Targeted Therapy | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Targeted Therapy | |
pubs.publication-status | Published | |
pubs.volume | 6 | |
pubs.embargo.terms | Not known | |
icr.researchteam | Targeted Therapy | |
dc.contributor.icrauthor | Harrington, Kevin | |